Pfizer delays coronavirus vaccine data for young children to test 3rd dose
Studies of coronavirus vaccine efficacy on younger children hit a speed-bump Friday, as Pfizer and BioNTech announced they will alter their clinical trial to include a third shot for children aged 6 months to 5 years after the two-dose regimen failed to live up to expectations. ... Read more»0